Naviter Wealth, LLC Novartis Ag Transaction History

Naviter Wealth, LLC

$814 Million
Q4 2024

A detailed history of Naviter Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Naviter Wealth, LLC holds 40,525 shares of NVS stock, worth $4.27 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

40,525

Previous 50,362 19.53%

Holding current value

$4.27 Million

Previous $5.79 Million 31.92%

% of portfolio

0.48%

Previous 0.82%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$96.78 - $117.18 $952,024 - $1.15 Million	-9,837 Reduced 19.53%	40,525 $3.94 Million
Q3 2024 Oct 16, 2024	BUY	$106.13 - $120.89 $56,355 - $64,192	531 Added 1.07%	50,362 $5.79 Million
Q2 2024 Aug 01, 2024	BUY	$92.57 - $107.37 $228,925 - $265,526	2,473 Added 5.22%	49,831 $5.31 Million
Q1 2024 Apr 18, 2024	BUY	$95.27 - $108.47 $584,862 - $665,897	6,139 Added 14.89%	47,358 $4.58 Million
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $748,863 - $824,098	8,116 Added 24.52%	41,219 $4.16 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $233,888 - $259,565	2,469 Added 8.06%	33,103 $3.37 Million
Q2 2023 Jul 20, 2023	BUY	$92.52 - $104.91 $370,172 - $419,744	4,001 Added 15.02%	30,634 $3.09 Million
Q1 2023 Apr 12, 2023	BUY	$80.03 - $92.81 $31,291 - $36,288	391 Added 1.49%	26,633 $2.45 Million
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $183,284 - $224,453	2,426 Added 10.19%	26,242 $2.38 Million
Q3 2022 Oct 27, 2022	BUY	$74.61 - $87.26 $141,759 - $165,794	1,900 Added 8.67%	23,816 $1.81 Million
Q2 2022 Jul 18, 2022	BUY	$80.52 - $93.75 $1.76 Million - $2.05 Million	21,916 New	21,916 $1.85 Million

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Naviter Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naviter Wealth, LLC with notifications on news.

Account

Naviter Wealth, LLC Novartis Ag Transaction History